Rapid approval of biological drugs eyed

Published: 2013-08-07 06:59:00

Updated: 2013-08-07 06:59:00

The Ministry of Food and Drug Safety (MFDS) announced on July 31 that it has revised the rule concerning the simplified screening of biological products, such as vaccines, requiring a state-run approval, as part of its effort to provide better support for the domestic drug makers to develop biolo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK